Nanotechnology in Drug Delivery

A Global Strategic Business Report

MCP-7808

RESEARCH DASHBOARD

OCT 2025

RELEASE DATE

3413

EXECUTIVE POOL

5850

PRICE

614

EXPERT INPUTS

36

COMPANIES

202

DATA TABLES

272

PAGES

15

EDITION

WHAT'S BEHIND OUR DATA?

140857226

DOMAIN TRANSCRIPTS

6080276

BRANDS TRACKED

1729341

FEATURED COMPANIES

22574

TOPICS COVERED

82719

MARKET SEGMENTS

91

KEY INDUSTRIES

1574

CURATION TEAM

4761909

DECISION MAKERS

EXECUTIVE ENGAGEMENTS BY TIER (1792)

60

CXO

89

VICE PRESIDENT

580

DIRECTOR

477

MANAGER

586

MARKETING

REQUEST FULL-STACK INDEX Includes 350+ pages validated sources

QUESTIONNAIRE EXECUTIVES DATA ROOM

OUR EXPERT PANELS

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

INFLUENCER INVITEE

WHY PARTICIPATE?

Expertise to the Power of YOU!

Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription

The Economist
MIT Technology Review
Harvard Business Review

Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.

MARKETGLASS

BASIC

Annual Prepaid Subscription
Single-User
10,000 Data Room Credits/Month
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use MarketGlass^TM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.

PREMIUM

Annual Prepaid Subscription
One Research Project With One Complimentary Update/Year
10-User License
10-User Peer-to-Peer Collaborative Features
200 Domain Expert Insights (With Name, Company, and Date)
50,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

ENTERPRISE

Annual Prepaid Subscription
Four Research Projects With One Complimentary Update/Year
25-User License
25-User Peer-to-Peer Collaborative Engagements
500 Domain Expert Insights (With Name, Company, and Date)
150,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

HIGHLIGHTS & REPORT INDEX

Global Nanotechnology in Drug Delivery Market to Reach US$122.7 Billion by 2030

The global market for Nanotechnology in Drug Delivery estimated at US$77.4 Billion in the year 2024, is expected to reach US$122.7 Billion by 2030, growing at a CAGR of 8.0% over the analysis period 2024-2030. Nanoparticles, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$35.6 Billion by the end of the analysis period. Growth in the Liposomes segment is estimated at 8.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$20.0 Billion While China is Forecast to Grow at 11.8% CAGR

The Nanotechnology in Drug Delivery market in the U.S. is estimated at US$20.0 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$30.6 Billion by the year 2030 trailing a CAGR of 11.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.1% and 7.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Nanotechnology in Drug Delivery Market - Key Trends and Drivers Summarized

Nanotechnology in drug delivery represents a groundbreaking advancement in medicine, providing a method to increase the efficiency, precision, and efficacy of drug therapies, particularly for challenging diseases like cancer and diabetes. Utilizing nanoparticles, which are typically under 100 nanometers in size, this technology allows for the precise targeting and controlled release of medications, minimizing side effects while maximizing therapeutic outcomes. These nanoparticles are crafted from a range of biodegradable materials including natural and synthetic polymers, lipids, and metals, making them highly adaptable to various biological environments. For instance, in diabetes management, nanotechnology has enabled the development of closed-loop insulin delivery systems that dynamically adjust to changing glucose levels, mimicking physiological insulin responses and significantly improving patient care. Additionally, nanoparticles can navigate complex biological barriers such as the blood-brain barrier, which is particularly advantageous for delivering chemotherapy agents directly to brain tumors, thus bypassing traditional delivery challenges.

The application of nanotechnology in drug delivery is transforming the treatment landscape for diseases that are difficult to manage with conventional methods. By facilitating the transportation of drugs across restrictive barriers within the body, nanoparticles enhance the bioavailability and efficacy of treatments. Advanced nanocarriers are designed to target specific cells or receptors, which is vital for treating conditions like multidrug-resistant cancer effectively. These carriers can utilize the body`s circulatory system to deliver drugs directly to targeted sites, such as tumor cells or specific areas of inflammation. Moreover, innovations in nanoparticle design are producing systems that respond to the unique environments of disease sites, such as pH-responsive or oxidative stress-responsive nanoparticles that activate in the tumor microenvironment, thereby enhancing the precision of treatments like radiotherapy. This ability to respond to specific physiological conditions maximizes the impact of the therapeutic agents while sparing healthy tissue from unnecessary exposure.

The growth of nanotechnology in drug delivery is driven by several key factors. Technological advancements in nanoparticle fabrication and nanoscale imaging have significantly broadened the applications and effectiveness of nanomedicines. Increased regulatory support and dedicated funding are accelerating the development and approval of innovative nanotechnology applications, supporting research that spans across various diseases and medical challenges. Moreover, the shift towards patient-centric healthcare underscores the demand for drug delivery systems that enhance patient compliance and quality of life. Nanotechnologies offer customized and less invasive treatment options that align with modern healthcare goals of reducing treatment durations and improving therapeutic outcomes. Additionally, collaborations across diverse scientific disciplines are propelling forward the capabilities of nanotechnologies, integrating insights from materials science, chemistry, biology, and pharmaceutical sciences to innovate and refine drug delivery systems. As global health challenges evolve, the flexibility and adaptability of nanotechnologies to address emerging public health concerns like antibiotic resistance and pandemic responses become increasingly crucial, promising a future where nanotechnology plays a pivotal role in advancing drug delivery and patient care.

SCOPE OF STUDY

The report analyzes the Nanotechnology in Drug Delivery market by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions, Other Technologies); Application (Oncology, Cardiovascular, Neurology, Anti-Inflammatory, Other Applications).

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..

SELECT PLAYERS

AbbVie Inc.; Aquanova AG; BlueWillow Biologics; Camurus AB; Celgene, Inc.; Ceramisphere Health Pty Limited; Cristal Therapeutics; CYTIMMUNE SCIENCES, Inc.; EnColl Corporation; EyePoint Pharmaceuticals; Lena Nanoceutics Ltd.; Nanobiotix; NanoCarrier Co., Ltd.; NanOlogy LLC; Nanospectra Biosciences, Inc.; Parvus Therapeutics Inc.; Selecta Biosciences; Starpharma Holdings Limited; Taiwan Liposome Co., ; Tarveda Therapeutics

AI INTEGRATIONS

We’re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights

Tariff Impact on Global Supply Chain Patterns

Global Economic Update

Nanotechnology in Drug Delivery – Global Key Competitors Percentage Market Share in 2024 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for 36 Players Worldwide in 2024 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Rising Prevalence of Chronic Diseases Expands Addressable Market for Nanomedicine

Advances in Nanoscale Engineering Drive Innovations in Drug Delivery Mechanisms

Increasing Investment in Biotechnology Research Strengthens Business Case for Nanotechnology

Personalized Medicine Trends Generate Demand for Nanotechnology-Enabled Drug Delivery

Global Health Challenges Catalyze Development of Novel Nanotherapeutics

Patent Expirations of Blockbuster Drugs Throw Spotlight on Nanodelivery as a Differentiation Strategy

Collaborations Between Pharma and Nanotech Companies Enhance Drug Efficacy and Safety

Technological Convergence Spurs Integrated Solutions in Nanotechnology and Drug Delivery

Aging Population and Associated Health Needs Drive Nanotechnology Applications

Market Entry of Startups Introduces Disruptive Innovations in Nanodelivery Systems

4. GLOBAL MARKET PERSPECTIVE

World Nanotechnology in Drug Delivery Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

World Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Nanoparticles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Nanoparticles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Liposomes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Liposomes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Nanocrystals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Nanocrystals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Nano Emulsions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Nano Emulsions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Anti-Inflammatory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Anti-Inflammatory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES

Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)

USA Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

USA Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

CANADA

Canada Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

Canada Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

JAPAN

Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)

Japan Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

Japan Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

CHINA

Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)

China Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

China Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

EUROPE

Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)

Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2025 & 2030

Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

FRANCE

Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)

France Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

France Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

GERMANY

Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)

Germany Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

Germany Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

ITALY

Italy Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

Italy Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

UNITED KINGDOM

Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)

UK Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

UK Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

SPAIN

Spain Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

Spain Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

RUSSIA

Russia Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

Russia Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

REST OF EUROPE

Rest of Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

ASIA-PACIFIC

Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)

Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Asia-Pacific 6-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

AUSTRALIA

Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)

Australia Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

Australia Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

INDIA

Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)

India Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

India Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

SOUTH KOREA

South Korea Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

South Korea Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

REST OF ASIA-PACIFIC

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

LATIN AMERICA

Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)

Latin America Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Latin America 6-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

ARGENTINA

Argentina Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

Argentina Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

BRAZIL

Brazil Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

Brazil Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

MEXICO

Mexico Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

Mexico Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

REST OF LATIN AMERICA

Rest of Latin America Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

MIDDLE EAST

Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)

Middle East Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Middle East 6-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

IRAN

Iran Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

Iran Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

ISRAEL

Israel Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

Israel Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

SAUDI ARABIA

Saudi Arabia Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

UNITED ARAB EMIRATES

UAE Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

UAE Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

REST OF MIDDLE EAST

Rest of Middle East Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

AFRICA

Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)

Africa Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa 6-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2025 & 2030

Africa Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa 6-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2025 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)	% VALIDATED RESEARCH *
AbbVie, Inc.	%
AccuRna	%
Alchemy Pharmatech Ltd.	%
Arcturus Therapeutics, Inc.	%
Axialys Innovations	%
BlueWillow Biologics	%
Cipla Ltd.	%
Cytimmune Science, Inc.	%
Dolomite Microfluidics	%
Double Bond Pharmaceutical	%

* Login to Participate & View Data Stacks

* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlass^TM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.

View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.

Scroll